ArticleFrontiers in oncology2021

A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL.

Chong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.